Back to Trades
Harlow John B. Jr.
Chief Commercial OfficerCIK 0002095554
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 3
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
Harlow John B. Jr., Chief Commercial Officer, accounts for 3 disclosed filings worth $1.4M, all concentrated in Esperion Therapeutics, Inc. (ESPR), active 2025–2026. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
3 loaded
| Jul 13 | ESPR Esperion Therapeutics, Inc. | Harlow John B. Jr. | Chief Commercial Officer | Disposed | $0 |
| Dec 8 | ESPR Esperion Therapeutics, Inc. | Harlow John B. Jr. | Chief Commercial Officer | Grant | $1.4M |
| Nov 17 | ESPR Esperion Therapeutics, Inc. | Harlow John B. Jr. | Chief Commercial Officer | Other | $0 |
3 filings